Austin Sarah, Hanson Erika N, Delacroix Emerson, Bacon Elizabeth, Rice John, Gerido Lynette Hammond, Rizzo Elizabeth, Pleasant Versha, Stoffel Elena M, Griggs Jennifer J, Resnicow Ken
Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
J Genet Couns. 2025 Feb;34(1):e1926. doi: 10.1002/jgc4.1926. Epub 2024 May 27.
Genetic testing for hereditary cancer syndromes can provide lifesaving information allowing for individualized cancer screening, prevention, and treatment. However, the determinants, both barriers and motivators, of genetic testing intention are not well described. A survey of barriers and motivators to genetic testing was emailed to adult patients eligible for genetic testing based on cancer diagnosis who previously have not had genetic testing (n = 201). Associations between barriers/motivators with testing intention and confidence were examined first by correlation followed by multivariable linear regression model holding constant potential covariates. Seven barrier items from two domains (logistics and genetic testing knowledge) were found to significantly negatively correlate with genetic testing intention. Unexpectedly, three barrier items had significant positive correlation with genetic testing intention; these were related to family worry (passing a condition on to future generations) and testing knowledge (needing more information on the genetic testing process and what it has to offer). Ten barrier items had significant negative correlation with confidence to get a genetic test and encompassed four domains: stigma, insurance/genetic discrimination, knowledge, and cost. All motivator items were associated with intention to get a genetic test, while none were associated with confidence. Multivariable analysis yielded six total barriers (five from the knowledge domain, one from cost domain) and two motivators (relieved to know and treatment impact) that were significantly associated with genetic testing intention or confidence when controlling for demographic characteristics. These findings indicate the need for tailored interventions to amplify motivating factors and counter-message barriers to enhance patient motivation and confidence to undergo testing.
遗传性癌症综合征的基因检测能够提供挽救生命的信息,从而实现个性化的癌症筛查、预防和治疗。然而,基因检测意愿的决定因素,包括障碍和动机,目前尚未得到充分描述。我们通过电子邮件对符合基因检测条件(基于癌症诊断)但此前未进行过基因检测的成年患者(n = 201)进行了一项关于基因检测障碍和动机的调查。首先通过相关性分析,然后采用多变量线性回归模型,并控制潜在协变量,来研究障碍/动机与检测意愿和信心之间的关联。发现来自两个领域(后勤和基因检测知识)的七个障碍项目与基因检测意愿显著负相关。出乎意料的是,三个障碍项目与基因检测意愿显著正相关;这些与家庭担忧(将某种疾病遗传给后代)和检测知识(需要更多关于基因检测过程及其所能提供的信息)有关。十个障碍项目与进行基因检测的信心显著负相关,涵盖四个领域:耻辱感、保险/基因歧视、知识和成本。所有动机项目都与进行基因检测的意愿相关,而与信心均无关联。多变量分析得出了六个与基因检测意愿或信心显著相关的障碍(五个来自知识领域,一个来自成本领域)和两个动机(了解后感到宽慰和治疗影响),这些都是在控制人口统计学特征时得出的。这些发现表明需要采取针对性的干预措施,以增强激励因素并消除障碍信息,从而提高患者进行检测的动机和信心。